Global Expansion Sidekick Health operates internationally with active presence across the United States and global markets, presenting opportunities to expand in payer-led environments and cross-border healthcare collaborations.

Insurer and Pharma Partnerships Products are developed in collaboration with health insurances and pharmaceutical companies, indicating a sales path focused on healthcare payers and pharma co-development deals for digital therapeutics and adherence programs.

Prescribable Therapy Sidekick Rx as a third business unit focuses on prescribable therapeutics, signaling opportunities to partner with clinics, endocrinology, obesity, and specialty care providers to drive prescription-based digital interventions like zanadio.

Recent Integrations Recent integrations with Ypsomed for autoinjectors and other digital health solutions suggest a strategy of embedding Sidekick capabilities into device-assisted therapies, enabling co-sell with device manufacturers and injectable therapy programs.

Clinical and MSK Growth Launch of musculoskeletal health and pain management programs expands addressable markets including chronic pain and MSK conditions, offering cross-sell potential to payer networks, employers, and health systems seeking digital outcomes-based care.